首页|MAD2L1在结直肠癌中的表达及与免疫浸润关系的研究

MAD2L1在结直肠癌中的表达及与免疫浸润关系的研究

扫码查看
目的 探讨干扰有丝分裂阻滞缺陷 2 样蛋白 1(MAD2L1)在结直肠癌组织中的表达及与免疫浸润的关系。方法 基于TCGA数据库分析结直肠癌组织及正常结直肠组织中MAD2L1 的表达差异,生存分析评价MAD2L1 表达水平与患者预后的关系,采用临床相关性分析研究结直肠癌与临床资料的相关性。使用Timer数据库gene模块分析探究MAD2L1 与免疫细胞群之间的关系。使用correlation模块评估与免疫检查点水平的相关性。使用correlation模块进行免疫细胞浸润的关联分析,分析结直肠癌组织中MAD2L1 的表达与免疫细胞浸润的关系。结果 与正常组织相比,结直肠癌组织中MAD2L1 表达上调;MAD2L1 高表达组与低表达组结直肠癌患者相比,N分期患者比例不同,差异具有统计学意义(P<0。05)。预后分析显示,MAD2L1 高表达组的患者生存期、无进展生存期均高于低表达组的患者,差异具有统计学意义(P<0。05)。多因素COX回归分析显示,年龄和T分期可作为影响结直肠癌患者预后的独立预后因子(P<0。05)。MAD2L1 与结直肠癌中CD8+T细胞(结肠癌:r=0。315,P<0。001;直肠癌r=0。352,P<0。001)、嗜中性粒细胞(结肠癌:r=0。195,P<0。001;直肠癌:r=0。278,P<0。001)浸润水平均呈正相关,与CD4+T细胞(结肠癌:r=-0。174,P<0。001;直肠癌:r=-0。381,P<0。001)浸润水平呈负相关。其中还与结肠癌中B细胞水平(r=0。125,P<0。05)呈正相关。在结肠癌中,MAD2L1 与PD-L1(r=0。159,P<0。05)呈正相关。在直肠癌中,MAD2L1 与PD-1(r=-0。241,P<0。05)呈负相关。结论 MAD2L1在结直肠癌中高表达,与结直肠癌良好的预后及肿瘤免疫浸润相关,可能是结直肠癌患者潜在的治疗靶点。
Study on the expression of MAD2L1 in colorectal cancer and its relationship with immune invasion
Objective To explore the expression of Mitotic Arrest Deficient 2 Like 1(MAD2L1)in colorectal cancer tissues and its relationship with immune infiltration.Methods Based on the TCGA database,the expression difference of MAD2L1 in colorectal cancer tissues and normal colorectal tissues was analyzed,survival analysis was used to evaluate the relationship between MAD2L1 expression level and patient prognosis,and clinical correlation analysis was used to study the correlation between colorectal cancer and clinical data.The Timer database gene module was used to analyze the relationship between MAD2L1 and immune cell groups.The correlation module was used to evaluate the correlation with the level of immune checkpoints.The correlation module was used for the correlation analysis of immune cell infiltration,and the relationship between the expression of MAD2L1 in colorectal cancer tissues and immune cell infiltration was analyzed.Results Compared with normal tissues,the expression of MAD2L1 in colorectal cancer tissues was upregulated;compared with the low-expression group of colorectal cancer patients,the proportion of N-stage patients in the MAD2L1 high-expression group was different,and the difference was statistically significant(P<0.05).Prognostic analysis showed that the survival period and progression-free survival period of patients in the MAD2L1 high-expression group were higher than those of patients in the low-expression group,and the difference was statistically significant(P<0.05).Multivariate COX regression analysis showed that age and T stage can be used as independent prognostic factors affecting the prognosis of colorectal cancer patients(P<0.05).MAD2L1 was positively correlated with the infiltration level of CD8+T cells(colorectal cancer:r=0.315,P<0.001;rectal cancer r=0.352,P<0.001)and neutrophils(colorectal cancer:r=0.195,P<0.001;rectal cancer:r=0.278,P<0.001)in colorectal cancer,and negatively correlated with the infiltration level of CD4+T cells(colorectal cancer:r=-0.174,P<0.001;rectal cancer:r=-0.381,P<0.001).It was also positively correlated with the level of B cells in colorectal cancer(r=0.125,P<0.05).In colorectal cancer,MAD2L1 was positively correlated with PD-L1(r=0.159,P<0.05).In rectal cancer,MAD2L1 was negatively correlated with PD-1(r=-0.241,P<0.05).Conclusion MAD2L1 is highly expressed in colorectal cancer,and is related to the good prognosis of colorectal cancer and tumor immune infiltration,and may be a potential therapeutic target for colorectal cancer patients.

MAD2L1colorectal cancerimmune infiltrationprognosis

刘萌萌、李付广

展开 >

郑州大学基础医学院,河南中医药大学第三附属医院 病理科,河南 郑州 450000

郑州大学基础医学院 微生物学与免疫学系,河南 郑州 450000

MAD2L1 结直肠癌 免疫浸润 预后

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(5)
  • 27